These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 18471035

  • 1. The cost of treating skeletal-related events in patients with prostate cancer.
    Lage MJ, Barber BL, Harrison DJ, Jun S.
    Am J Manag Care; 2008 May; 14(5):317-22. PubMed ID: 18471035
    [Abstract] [Full Text] [Related]

  • 2. The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer.
    Delea T, Langer C, McKiernan J, Liss M, Edelsberg J, Brandman J, Sung J, Raut M, Oster G.
    Oncology; 2004 May; 67(5-6):390-6. PubMed ID: 15713995
    [Abstract] [Full Text] [Related]

  • 3. Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice.
    Delea T, McKiernan J, Brandman J, Edelsberg J, Sung J, Raut M, Oster G.
    J Support Oncol; 2006 May; 4(7):341-7. PubMed ID: 16892696
    [Abstract] [Full Text] [Related]

  • 4. Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications.
    Krupski TL, Foley KA, Baser O, Long S, Macarios D, Litwin MS.
    J Urol; 2007 Oct; 178(4 Pt 1):1423-8. PubMed ID: 17706711
    [Abstract] [Full Text] [Related]

  • 5. Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases.
    Hagiwara M, Delea TE, Saville MW, Chung K.
    Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):23-7. PubMed ID: 23146970
    [Abstract] [Full Text] [Related]

  • 6. Canadian health care institution resource utilization resulting from skeletal-related events.
    Habib MJ, Merali T, Mills A, Uon V.
    Hosp Pract (1995); 2014 Feb; 42(1):15-22. PubMed ID: 24566592
    [Abstract] [Full Text] [Related]

  • 7. The economic burden associated with skeletal-related events in patients with bone metastases secondary to solid tumors in Belgium.
    Body JJ, Chevalier P, Gunther O, Hechmati G, Lamotte M.
    J Med Econ; 2013 Feb; 16(4):539-46. PubMed ID: 23425250
    [Abstract] [Full Text] [Related]

  • 8. Healthcare costs associated with skeletal-related events in breast cancer patients with bone metastases.
    Hagiwara M, Delea TE, Chung K.
    J Med Econ; 2014 Mar; 17(3):223-30. PubMed ID: 24494707
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy.
    Sekine I, Nokihara H, Yamamoto N, Kunitoh H, Ohe Y, Tamura T.
    Lung Cancer; 2009 Aug; 65(2):219-22. PubMed ID: 19081161
    [Abstract] [Full Text] [Related]

  • 10. Economic Evaluation of Treating Skeletal-Related Events among Prostate Cancer Patients.
    Zhong Y, Valderrama A, Yao J, Donga P, Bilir P, Neumann PJ.
    Value Health; 2018 Mar; 21(3):304-309. PubMed ID: 29566837
    [Abstract] [Full Text] [Related]

  • 11. Payer costs for inpatient treatment of pathologic fracture, surgery to bone, and spinal cord compression among patients with multiple myeloma or bone metastasis secondary to prostate or breast cancer.
    Barlev A, Song X, Ivanov B, Setty V, Chung K.
    J Manag Care Pharm; 2010 Mar; 16(9):693-702. PubMed ID: 21067255
    [Abstract] [Full Text] [Related]

  • 12. The economic burden of skeletal-related events among elderly men with metastatic prostate cancer.
    Jayasekera J, Onukwugha E, Bikov K, Mullins CD, Seal B, Hussain A.
    Pharmacoeconomics; 2014 Feb; 32(2):173-91. PubMed ID: 24435407
    [Abstract] [Full Text] [Related]

  • 13. The Clinical and Economic Impacts of Skeletal-Related Events Among Medicare Enrollees With Prostate Cancer Metastatic to Bone.
    McDougall JA, Bansal A, Goulart BH, McCune JS, Karnopp A, Fedorenko C, Greenlee S, Valderrama A, Sullivan SD, Ramsey SD.
    Oncologist; 2016 Mar; 21(3):320-6. PubMed ID: 26865591
    [Abstract] [Full Text] [Related]

  • 14. Clinical and economic burden of bone metastasis and skeletal-related events in prostate cancer.
    Yong C, Onukwugha E, Mullins CD.
    Curr Opin Oncol; 2014 May; 26(3):274-83. PubMed ID: 24626126
    [Abstract] [Full Text] [Related]

  • 15. Hospital resource utilization and treatment cost of skeletal-related events in patients with metastatic breast or prostate cancer: estimation for the Portuguese National Health System.
    Félix J, Andreozzi V, Soares M, Borrego P, Gervásio H, Moreira A, Costa L, Marcelo F, Peralta F, Furtado I, Pina F, Albuquerque C, Santos A, Passos-Coelho JL, Portuguese Group for the Study of Bone Metastases.
    Value Health; 2011 Jun; 14(4):499-505. PubMed ID: 21669375
    [Abstract] [Full Text] [Related]

  • 16. Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999-2006.
    Sathiakumar N, Delzell E, Morrisey MA, Falkson C, Yong M, Chia V, Blackburn J, Arora T, Kilgore ML.
    Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):177-83. PubMed ID: 21403668
    [Abstract] [Full Text] [Related]

  • 17. Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancer.
    Delea TE, McKiernan J, Brandman J, Edelsberg J, Sung J, Raut M, Oster G.
    J Thorac Oncol; 2006 Jul; 1(6):571-6. PubMed ID: 17409919
    [Abstract] [Full Text] [Related]

  • 18. The benefits of timely intervention with zoledronic acid in patients with metastatic prostate cancer to bones: a retrospective study of the US Veterans Affairs population.
    Velde NV, Wu EQ, Guo A, Lu M, Yu AP, Sharma H, Liu J, Fan CP, Shi L.
    Prostate Cancer Prostatic Dis; 2011 Mar; 14(1):79-84. PubMed ID: 21173792
    [Abstract] [Full Text] [Related]

  • 19. Cost of skeletal complications from bone metastases in six European countries.
    Pereira J, Body JJ, Gunther O, Sleeboom H, Hechmati G, Maniadakis N, Terpos E, Acklin YP, Finek J, von Moos R.
    J Med Econ; 2016 Jun; 19(6):611-8. PubMed ID: 26849381
    [Abstract] [Full Text] [Related]

  • 20. Clinical, economic and humanistic burdens of skeletal-related events associated with bone metastases.
    Carter JA, Ji X, Botteman MF.
    Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):483-96. PubMed ID: 23862654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.